agilon health, inc. (NYSE:AGL) Receives $8.03 Average Price Target from Brokerages

Shares of agilon health, inc. (NYSE:AGL) have received a consensus rating of “Hold” from the twenty brokerages that are currently covering the company, MarketBeat.com reports. Two research analysts have rated the stock with a sell rating, fourteen have given a hold rating and four have assigned a buy rating to the company. The average twelve-month price target among brokerages that have issued a report on the stock in the last year is $8.03.

A number of research firms recently issued reports on AGL. Bank of America downgraded shares of agilon health from a “buy” rating to an “underperform” rating and set a $3.00 price objective for the company. in a report on Wednesday, October 2nd. Evercore ISI decreased their price target on shares of agilon health from $7.00 to $4.00 and set an “in-line” rating for the company in a research note on Tuesday, October 8th. Benchmark reissued a “buy” rating and set a $9.00 price objective on shares of agilon health in a report on Thursday, August 8th. Deutsche Bank Aktiengesellschaft lowered their target price on agilon health from $5.00 to $4.00 and set a “hold” rating on the stock in a research note on Friday, August 9th. Finally, Royal Bank of Canada restated an “outperform” rating and issued a $8.00 price objective on shares of agilon health in a research note on Wednesday, August 7th.

agilon health Price Performance

Shares of NYSE AGL opened at $3.22 on Friday. The company has a market capitalization of $1.32 billion, a PE ratio of -4.41 and a beta of 0.54. The company has a quick ratio of 1.36, a current ratio of 1.36 and a debt-to-equity ratio of 0.04. The stock’s 50 day moving average price is $4.13 and its 200-day moving average price is $5.31. agilon health has a twelve month low of $2.99 and a twelve month high of $20.37.

agilon health (NYSE:AGL) last posted its quarterly earnings data on Tuesday, August 6th. The company reported ($0.07) earnings per share for the quarter, hitting the consensus estimate of ($0.07). agilon health had a negative return on equity of 29.91% and a negative net margin of 5.57%. The business had revenue of $1.48 billion for the quarter, compared to analysts’ expectations of $1.56 billion. During the same quarter in the previous year, the firm earned ($0.04) earnings per share. The business’s revenue was up 38.7% on a year-over-year basis. On average, equities analysts anticipate that agilon health will post -0.32 EPS for the current year.

Insider Buying and Selling

In other agilon health news, CEO Steven Sell bought 20,000 shares of agilon health stock in a transaction that occurred on Thursday, September 12th. The stock was acquired at an average cost of $3.36 per share, for a total transaction of $67,200.00. Following the completion of the transaction, the chief executive officer now directly owns 67,590 shares in the company, valued at $227,102.40. This represents a 0.00 % increase in their ownership of the stock. The purchase was disclosed in a legal filing with the SEC, which is available through this link. 3.20% of the stock is currently owned by company insiders.

Hedge Funds Weigh In On agilon health

Hedge funds and other institutional investors have recently bought and sold shares of the stock. Arizona State Retirement System increased its position in shares of agilon health by 2.5% during the 2nd quarter. Arizona State Retirement System now owns 85,989 shares of the company’s stock valued at $562,000 after purchasing an additional 2,070 shares during the last quarter. Swiss National Bank lifted its holdings in shares of agilon health by 0.6% in the 1st quarter. Swiss National Bank now owns 602,800 shares of the company’s stock worth $3,677,000 after acquiring an additional 3,400 shares during the last quarter. J.Safra Asset Management Corp boosted its stake in shares of agilon health by 626.1% in the 2nd quarter. J.Safra Asset Management Corp now owns 4,204 shares of the company’s stock valued at $27,000 after purchasing an additional 3,625 shares in the last quarter. Neo Ivy Capital Management bought a new position in shares of agilon health during the 4th quarter valued at $47,000. Finally, Renaissance Capital LLC grew its holdings in shares of agilon health by 3.0% during the 1st quarter. Renaissance Capital LLC now owns 191,122 shares of the company’s stock valued at $1,166,000 after purchasing an additional 5,551 shares during the last quarter.

About agilon health

agilon health, inc. provides healthcare services for seniors through primary care physicians in the communities of the United States. It offers a platform that manages the total healthcare needs of the patients by subscription-like per-member per-month. The company was formerly known as Agilon Health Topco, Inc and changed its name to agilon health, inc.